This creates a need to examine the insulin-deprivation counterpart to our hyperinsulinemia model system, with the latter a question that would need to addressed in vivo and/or with insulin receptor-deficient mast cells in vitro or in vivo. The gene discussed is INSR; the disease is Hyperinsulinemia.